Home/Filings/4/0001726978-24-000107
4//SEC Filing

Miller Mark 4

Accession 0001726978-24-000107

CIK 0001726978other

Filed

Nov 7, 7:00 PM ET

Accepted

Nov 8, 6:29 PM ET

Size

15.6 KB

Accession

0001726978-24-000107

Insider Transaction Report

Form 4
Period: 2024-11-06
Miller Mark
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2024-11-06$10.00/sh+3,295$32,95033,295 total
  • Exercise/Conversion

    Class A Common Stock

    2024-11-07$10.00/sh+58,327$583,27088,327 total
  • Sale

    Class A Common Stock

    2024-11-07$110.21/sh57,927$6,384,13530,400 total
  • Sale

    Class A Common Stock

    2024-11-07$111.16/sh400$44,46430,000 total
  • Exercise/Conversion

    Director Stock Options (right to buy)

    2024-11-063,29558,327 total
    Exercise: $10.00Exp: 2028-04-26Class A Stock (3,295 underlying)
  • Exercise/Conversion

    Director Stock Options (right to buy)

    2024-11-0758,3270 total
    Exercise: $10.00Exp: 2028-04-26Class A Stock (58,327 underlying)
  • Sale

    Class A Common Stock

    2024-11-06$110.00/sh3,295$362,45030,000 total
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.03 to $111.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  • [F3]The shares subject to the option shall vest and become exercisable, subject to continued service, in 12 equal quarterly installments over the three (3) year period following the grant date; provided, that all shares subject to the option will vest and become exercisable upon a "change in control" (as defined in the issuer's omnibus incentive plan).

Issuer

Goosehead Insurance, Inc.

CIK 0001726978

Entity typeother

Related Parties

1
  • filerCIK 0001737949

Filing Metadata

Form type
4
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 6:29 PM ET
Size
15.6 KB